chr5-13780935-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001369.3(DNAH5):​c.8845C>G​(p.Gln2949Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00206 in 1,613,760 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Q2949Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0014 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 7 hom. )

Consequence

DNAH5
NM_001369.3 missense

Scores

3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:8B:5

Conservation

PhyloP100: 1.27

Publications

4 publications found
Variant links:
Genes affected
DNAH5 (HGNC:2950): (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009]
DNAH5 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03359276).
BP6
Variant 5-13780935-G-C is Benign according to our data. Variant chr5-13780935-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 281131.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00139 (212/152290) while in subpopulation NFE AF = 0.00281 (191/68014). AF 95% confidence interval is 0.00248. There are 2 homozygotes in GnomAd4. There are 107 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001369.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAH5
NM_001369.3
MANE Select
c.8845C>Gp.Gln2949Glu
missense
Exon 53 of 79NP_001360.1Q8TE73

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAH5
ENST00000265104.5
TSL:1 MANE Select
c.8845C>Gp.Gln2949Glu
missense
Exon 53 of 79ENSP00000265104.4Q8TE73
DNAH5
ENST00000681290.1
c.8800C>Gp.Gln2934Glu
missense
Exon 53 of 79ENSP00000505288.1A0A7P0Z455

Frequencies

GnomAD3 genomes
AF:
0.00139
AC:
212
AN:
152172
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00281
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00157
AC:
393
AN:
250954
AF XY:
0.00153
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000462
Gnomad NFE exome
AF:
0.00315
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.00213
AC:
3116
AN:
1461470
Hom.:
7
Cov.:
32
AF XY:
0.00209
AC XY:
1517
AN XY:
727050
show subpopulations
African (AFR)
AF:
0.000389
AC:
13
AN:
33452
American (AMR)
AF:
0.000313
AC:
14
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39674
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.000711
AC:
38
AN:
53414
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5758
European-Non Finnish (NFE)
AF:
0.00267
AC:
2964
AN:
1111748
Other (OTH)
AF:
0.00141
AC:
85
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
152
304
457
609
761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00139
AC:
212
AN:
152290
Hom.:
2
Cov.:
32
AF XY:
0.00144
AC XY:
107
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41578
American (AMR)
AF:
0.000131
AC:
2
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00281
AC:
191
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00242
Hom.:
1
Bravo
AF:
0.00129
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00256
AC:
22
ExAC
AF:
0.00175
AC:
212
EpiCase
AF:
0.00229
EpiControl
AF:
0.00202

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
4
2
not provided (6)
-
1
2
Primary ciliary dyskinesia (3)
-
3
-
Primary ciliary dyskinesia 3 (3)
-
-
1
See cases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
7.8
DANN
Uncertain
0.99
DEOGEN2
Benign
0.33
T
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.47
N
LIST_S2
Uncertain
0.94
D
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.034
T
MetaSVM
Benign
-0.89
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
1.3
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.22
Sift
Benign
0.036
D
Polyphen
0.0020
B
Vest4
0.75
MVP
0.54
MPC
0.10
ClinPred
0.025
T
GERP RS
3.7
Varity_R
0.19
gMVP
0.62
Mutation Taster
=36/64
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147688221; hg19: chr5-13781044; API